As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of BTCS Labs Inc. The largest reported stake is Charles W. Allen's, at 80%. One filing is on record since December 3, 2025 (Schedule 13D, December 3, 2025).
Sell to companies like BTCS Labs Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Charles W. Allen · Sole voting: 100,000 · Shared voting: 0 · Sole dispositive: 100,000 · Shared dispositive: 0 · SCHEDULE 13D, 2025-12-03
- · Reporting person: BTCS Equity Partners LLC · Sole voting: 400,000 · Shared voting: 0 · Sole dispositive: 400,000 · Shared dispositive: 0 · SCHEDULE 13D, 2025-12-03
- · Holder: Charles W. Allen · Percent: 80% · SCHEDULE 13D
- · Holder: Charles W. Allen · Percent: 80% · Shares: 100,000 · SCHEDULE 13D
BTCS Labs Inc. has 1 Schedule 13D or 13G filing on record since 2025-12-03. 1 holder's latest filing reports 5% or more of common stock, $0.001 par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 80% | 100,000 | SCHEDULE 13D, 2025-12-03 | 2025-10-03 |
Holding shares or following this stake? See who's behind BTCS Labs Inc. and the warning signs.
Free to see. No signup.
Watch BTCS Labs Inc.
Get an email when BTCS Labs Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on BTCS Labs Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on BTCS Labs Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BTCS Labs Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Charles W. Allen | 100,000 | 0 | 100,000 | 0 | SCHEDULE 13D, 2025-12-03 |
| BTCS Equity Partners LLC | 400,000 | 0 | 400,000 | 0 | SCHEDULE 13D, 2025-12-03 |
The latest filing identifies BTCS Labs Inc. by CUSIP 000000000 and gives its principal executive office as 303 W. LANCASTER AVE. #135, WAYNE, PA 19087 (SCHEDULE 13D, 2025-12-03).
Source of funds (Item 3)
On September 22, 2025, Charles Allen purchased 100,000 shares of the Issuer's common stock for an aggregate purchase price of $10,000. On September 29, 2025, BTCS Equity Partners LLC, an entity over which Mr. Allen exercises voting and dispositive control, purchased 400,000 shares of the Issuer's common stock for an aggregate purchase price of $40,000. Together, these purchases represented 100% of our 500,000 issued and outstanding shares of common stock as of that date. As a result of these purchases, Mr.Charles W. Allen, SCHEDULE 13D, 2025-12-03
Purpose of Transaction (Item 4)
Charles W. Allen
Mr. Allen is the Chief Executive Officer, President, Secretary, Treasurer, and sole director of the Issuer. He acquired all of his securities with the purpose of exercising control.Item 4 of the SCHEDULE 13D filed 2025-12-03
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-12-03 | Charles W. Allen | 80% | SCHEDULE 13D |
Tools for this story
Each opens in a new tab, filled in for BTCS Labs Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.